People news: Boston Scientific, Watson
Watson Pharmaceuticals has installed a Global Generics Management Team. The company announced the new team Thursday. President and CEO Paul Bisaro said in a statement the team will help the company “capitalize on the momentum” of the company since its April acquisition of Actavis. Andrew Boyer is leading the US generics business, which accounts for about 10% of the US market. Jean-Guy Goulet is the lead for the Canada and Latin American businesses and Lars Ramneborn is head of European generics. Siggi Olaffson is President of Global Generics.